TORONTO, July 15 /CNW/ - Dalton Pharma Services is pleased to announce the expansion of its Contract - Analytical Services with the commissioning of two validated LC-MS/MS instruments which have been qualified for GMP testing of pharmaceutical products. The new equipment will assist in the identification, quantification of related substances, pharmaceutical degradation products, and impurities to support the preparation of registration dossiers for clients' drug development programs.

"Our commitment to accelerate the drug discover and development process continues as we add to our state-of-the -art instrumentation to support GMP API synthesis, sterile dose formulation and sterile fill method validation and other outsourced analytical projects including stability studies, bioanalytical development and analysis," said Peter Pekos, President and CEO. Dalton continues to develop and grow its analytical capabilities to enhance it's commitment to quality, responsiveness, flexibility and innovation through the supply of unparalleled contract pharmaceutical development services.

About Dalton Pharma Services

Dalton Chemical Laboratories Inc. o/a Dalton Pharma Services is a Health Canada approved contract pharmaceutical manufacturer that supplies chemistry and analytical services to the biotechnology and pharmaceutical industries in the areas of chemistry, medicinal chemistry and fine chemical manufacture. Dalton Provides cGMP manufacturing and sterile filling services to its customers at any stage of the regulatory process (Phase I, II, III or commercial). In its state of the art cGMP facilities, Dalton produces active pharmaceutical ingredients at the gram or kilogram scale. Dalton conducts sterile fills to produce batches of finished drug product in vials or syringes, either aseptically filled or terminally sterilized, under fully validated conditions. In addition, Dalton's analytical chemistry laboratory offers method development, validation and ICH stability programs to its clients.

For Further information: Peter Pekos, President & CEO, Dalton Pharma Services,
Tel: (416) 661-2102,    Fax: (416) 661-2108